Article

Activation of ErbB2 during Wallerian Degeneration of Sciatic Nerve

Department of Biology, College of Arts and Sciences, KyungHee University, Seoul, 130-701 Korea.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 12/1997; 17(21):8293-9.
Source: PubMed

ABSTRACT

We used anti-phosphopeptide-immunodetecting antibodies as immunohistochemical reagents to define the location and activity state of p185(erbB2) during Wallerian degeneration. Nerve damage induces a phosphorylation event at Y1248, a site that couples p185(erbB2) to the Ras-Raf-MAP kinase signal transduction pathway. Phosphorylation of p185(erbB2) occurs within Schwann cells and coincides in time and space with Schwann cell mitotic activity, as measured by bromodeoxyuridine uptake. These visual images of receptor autophosphorylation link activation of p185(erbB2) to the Schwann cell proliferation that accompanies nerve regeneration.

Download full-text

Full-text

Available from: Scott L Pomeroy
  • Source
    • "During Wallerian degeneration, a process of gradual nerve degeneration in the distal stump of the injury site when the peripheral nervous system (PNS) is injured, axons and myelin sheaths are degenerated and removed for regrowing axons. When axons outgrow from the nerve ending sites toward the distal stump at the site of injury, Schwann cells remyelinate the new axons [14, 15]. Enhancing the axonal regrowth by any small compounds, it can be therapeutic for improving PNS nerve regeneration. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aucubin is an iridoid glycoside with a wide range of biological activities, including anti-inflammatory, anti-microbial, anti-algesic as well as anti-tumor activities. Recently, it has been shown that aucubin prevents neuronal death in the hippocampal CA1 region in rats with diabetic encephalopathy. In addition, it has protective effects on H2O2-induced apoptosis in PC12 cells. We have shown here that aucubin promotes neuronal differentiation and neurite outgrowth in neural stem cells cultured primarily from the rat embryonic hippocampus. We also investigated whether aucubin facilitates axonal elongation in the injured peripheral nervous system. Aucubin promoted lengthening and thickness of axons and re-myelination at 3 weeks after sciatic nerve injury. These results indicate that administration of aucubin improved nerve regeneration in the rat model of sciatic nerve injury, suggesting that aucubin may be a useful therapeutic compound for the human peripheral nervous system after various nerve injuries.
    Full-text · Article · Sep 2014
  • Source
    • "Taken together, these findings show that blocking ErbB2 alone is sufficient to revert the disorganized morphology of 10A L2 acini to a normal morphology similar to that of 10A cont acini. The increase of pErk1/2 in the 10A L2 cells (see Figure 3A) is likely due to activation of ErbB2; it is known that phosphorylation of ErbB2 can be coupled to the Ras-MAPK pathway [43,44]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lysyl oxidase-like 2 (LOXL2) is a matrix remodeling enzyme that has been shown to play a key role in invasion and metastasis of breast carcinoma cells. However, very little is known about its role in normal tissue homeostasis. Here, we investigate the effects of LOXL2 expression in normal mammary epithelial cells in order to gain insight into how LOXL2 mediates cancer progression. LOXL2 was expressed in MCF10A normal human mammary epithelial cells. 3D acinar morphogenesis of these cells was assessed, as well as the ability of the cells to form branching structures on extracellular matrix (ECM)-coated surfaces. Transwell invasion assays were used to assess the invasive properties of the cells. Clinically relevant inhibitors of Human Epidermal Growth Factor Receptor 2 (ErbB2), lapatinib and Herceptin (Traztuzumab), were used to investigate the role of ErbB2 signaling in this model. A retrospective study on a previously published breast cancer patient dataset was carried out using Disease Specific Genomic Analysis (DSGA) to investigate the correlation of LOXL2 mRNA expression level with metastasis and survival of ErbB2 positive breast cancer patients. Fluorescence staining of the acini revealed increased proliferation, decreased apoptosis, and disrupted polarity leading to abnormal lumen formation in response to LOXL2 expression in MCF10A cells. When plated onto ECM, the LOXL2-expressing cells formed branching structures and displayed increased invasion. We noted that LOXL2 induced ErbB2 activation through reactive oxygen species (ROS) production, and ErbB2 inhibition using Herceptin or lapatinib abrogated the effects of LOXL2 on MCF10A cells. Finally, we found LOXL2 expression to be correlated with decreased overall survival and metastasis-free survival in breast cancer patients with ErbB2 positive tumors. These findings suggest that LOXL2 expression in normal epithelial cells can induce abnormal changes that resemble oncogenic transformation and cancer progression, and that these effects are driven by LOXL2-mediated activation of ErbB2. LOXL2 may also be a beneficial marker for breast cancers patients that could benefit most from anti-ErbB2 therapy.
    Full-text · Article · Aug 2013 · Breast cancer research: BCR
  • Source
    • "It is unclear how injury initiates neuregulin-Erb signaling, how neuregulin-Erb signaling propagates anterogradely, and how, if at all, do Nmnat and neuregulin-Erb signaling cascades relate one to the other. Notably, neuregulin-Erb interactions may regulate both myelination and demyelination [25-31]. It has been suggested that BACE1 (β-amyloid precursor protein cleaving enzyme 1), which also cleaves neuregulin, regulates myelination and remyelination [32-34]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Traumatic injury to peripheral nerves results in the loss of neural functions. Recovery by regeneration depends on the cellular and molecular events of Wallerian degeneration that injury induces distal to the lesion site, the domain through which severed axons regenerate back to their target tissues. Innate-immunity is central to Wallerian degeneration since innate-immune cells, functions and molecules that are produced by immune and non-immune cells are involved. The innate-immune response helps to turn the peripheral nerve tissue into an environment that supports regeneration by removing inhibitory myelin and by upregulating neurotrophic properties. The characteristics of an efficient innate-immune response are rapid onset and conclusion, and the orchestrated interplay between Schwann cells, fibroblasts, macrophages, endothelial cells, and molecules they produce. Wallerian degeneration serves as a prelude for successful repair when these requirements are met. In contrast, functional recovery is poor when injury fails to produce the efficient innate-immune response of Wallerian degeneration.
    Full-text · Article · Aug 2011 · Journal of Neuroinflammation
Show more

We use cookies to give you the best possible experience on ResearchGate. Read our cookies policy to learn more.